Atropine sulfate is an antimuscarinic agent used as a cycloplegic and mydriatic. The eye drops are used in the treatment of iritis and uveitis to immobilise the iris and ciliary muscle and to prevent or break down adhesions.

Since it is a powerful cycloplegic it is used in the determination of refraction in children below six years and children with convergent strabismus.
This report contains market size and forecasts of Atropine Eye Drop in global, including the following market information:
Global Atropine Eye Drop Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Atropine Eye Drop Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Atropine Eye Drop companies in 2021 (%)
The global Atropine Eye Drop market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
0.001 Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Atropine Eye Drop include Martindale Pharma，Ethypharm, Aspire Pharma Ltd, Bausch & Lomb U.K Limited and OSRX, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Atropine Eye Drop manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Atropine Eye Drop Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Atropine Eye Drop Market Segment Percentages, by Type, 2021 (%)
0.001
0.005
0.01
Global Atropine Eye Drop Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Atropine Eye Drop Market Segment Percentages, by Application, 2021 (%)
Hospital
Ophthalmic Clinic
Pharmacy
Others
Global Atropine Eye Drop Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Atropine Eye Drop Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Atropine Eye Drop revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Atropine Eye Drop revenues share in global market, 2021 (%)
Key companies Atropine Eye Drop sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Atropine Eye Drop sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Martindale Pharma，Ethypharm
Aspire Pharma Ltd
Bausch & Lomb U.K Limited
OSRX